DEA Promotes Claim That Marijuana Could Be More Likely To Cause Psychosis Than Meth

The Drug Enforcement Administration (DEA) is giving weight to the idea that marijuana could be more likely to cause psychosis than methamphetamine is—promoting a recent article where a psychiatrist indicated that the jury is out on the question.

In an email blast on Wednesday, DEA’s Just Think Twice campaign shared a link to the story from The Lund Report, with a subject line that asks: “Meth or Cannabis…Which Raises Risk of Psychosis More?”

“Studies have linked early and heavy use of cannabis to schizophrenia and psychosis,” DEA said, while prominently featuring a quote from Oregon-based psychiatrist David Rettew, who said there’s “overwhelming evidence that cannabis use, particularly for young people, changes the brain, and this is particularly true for adolescents.”

“But when it comes to psychosis, there’s really strong evidence at this point that cannabis raises the risk of psychotic disorders more than other drugs, even methamphetamines, which is surprising,” Rettew said.

While that was the only reference to meth in the original article, DEA evidently felt the standalone quote warranted more attention, with a subject line that indicated it was a key component of the reporting in the agency’s view.

This comes amid lingering questions about how DEA will navigate a pending marijuana rescheduling proposal that was initiated under the Biden administration. And while the agency has long been known to promote sensational claims about the risks of cannabis use, it appears there’s been a stepped-up push to reinforce that message, particularly for youth.

For example, DEA recently teamed up with an anti-marijuana organization to mark “National Prevention Week,” promoting a campaign that encourages people to share memes with dubious claims about the effects of cannabis—including the theory that it is a “gateway drug” to using other substances.

The memes ran the gamut, citing certain reports and studies that have been contradicted by other research. One meme claimed that cannabis use is associated with a 50 percent decrease in sperm count, which the DEA-promoted meme suggested could contribute to infertility.

In March, DEA separately promoted an “Anti-420 Day” campaign with Johnny’s Ambassadors that recruited students to send short videos warning their peers about marijuana use.

The plan was to “flood” Instagram with the short-form videos that would feature students talking about “why young people should not use THC.”

DEA has developed a reputation for its awkward messaging and educational materials around youth drug use.

Keep reading

Nebraska Lawmakers Move Forward With Plan To Outlaw Most Consumable Hemp And THC Products

A legislative proposal that would ban most consumable hemp and other THC products in Nebraska advanced Tuesday without amendments as opponents blocked changes.

Throughout a four-hour debate on Legislative Bill 316, from state Sen. Kathleen Kauth (R) of the Millard area, only a handful of senators spoke. That’s because of pointed opposition from state Sen. John Cavanaugh (D) of Omaha, who filed nearly 30 motions or amendments throughout the bill’s life, largely to push senators toward considering regulations instead of a ban.

LB 316 advanced 32–15 with 32 of the 33 Republicans voting for it and all 15 Democrats voting against. The Legislature’s one nonpartisan progressive was not in attendance.

State Sen. Dan McKeon (R) of Amherst, who was “present, not voting” on advancing the bill, said he did so to wait for possible future changes. He said he recently toured a consumable hemp shop in his district and has concerns about whether the bill could freeze those operations.

LB 316 would prohibit raw hemp above 0.3 percent tetrahydrocannabinol (THC) of any concentration and for processed hemp the lesser of 0.3 percent THC on a total weight basis or 10 milligrams per package, effective January 1. The mature stalks of Cannabis sativa and its fiber, oil, cake and any other naturally derived products would not be considered hemp, leaving a narrow legal path for some products such as fibers and textiles.

If the bill passed, it would include a “consumer safe harbor period” through the end of 2025 to give consumers time to discard any “illegal hemp” as newly defined under LB 316. Legal products would face an additional 10 percent wholesale tax at the time of purchase.

Keep reading

London Mayor Backs Marijuana Decriminalization After A Commission He Created Recommends Reform

The mayor of London is voicing support for the decriminalization of marijuana following the release of a comprehensive report the government commissioned that ultimately determined that criminalizing people over simple possession of cannabis does more harm than good and disproportionately impacts minority communities.

On Wednesday, London Mayor Sadiq Khan said the report from the independent London Drugs Commission (LDC), which he established, “makes a compelling, evidenced-based case for the decriminalization of possession of small quantities of natural cannabis.”

While the policy recommendation to move marijuana from the Misuse of Drugs Act to the Psychoactive Substances Act has been described as decriminalization, the proposal to remove any criminal penalties associated with low-level possession and stop police from conducting searches people over the smell of cannabis would effectively be non-commercial legalization.

What the report expressly does not recommend, however, is legalizing and regulating cannabis sales—at least for now. That comes as a disappointment to advocates, who feel the debate over reform and evidence from jurisdictions that have taken that step sufficiently shows that enacting commercial legalization would promote public safety with minimal risk.

“We need fresh thinking on how to reduce the substantial harms associated with drug-related crime in our communities,” the mayor said in a statement. “Better education, improved healthcare and more effective, equitable policing of cannabis use are long overdue.”

Keep reading

One Out Of Four Indian Tribes In The U.S. Is Now Involved In Marijuana Or Hemp Programs, New Map Shows

A new infographic from an advocacy group representing Native American tribes in the legal cannabis industry shows that more than a fourth of Indigenous communities in the continental United States are now involved with marijuana or hemp programs.

The map, created by the Indigenous Cannabis Industry Association (ICIA) in collaboration with the law firm Vicente, shows the locations of more than 100 tribal marijuana and hemp programs across the country.

Overall, approximately 26 percent of the 358 federally recognized Indigenous communities in the continental U.S. are now involved in some sort of cannabis program, the groups said.

The data, they said in a press release, “shows that the Indigenous cannabis industry is trending upward in terms of jobs, community development, and overall industry growth, with many Tribes currently scaling to meet demands for global cannabis distribution.”

“Since the first regulated Indigenous cannabis storefront opened almost 10 years ago in Washington State,” the groups said, “dozens of sovereign Indigenous communities have created their own unique regulatory systems to govern cannabis cultivation, production and sales.”

Keep reading

Marijuana And Alcohol Businesses Should Join The Hemp Industry In The Fight For Regulation Instead Of Prohibition

In recent months, leading organizations and companies in the alcohol and marijuana space have jumped into the hemp sector, offering their support for clear federal legalization and robust oversight of hemp products.

The U.S. Hemp Roundtable, the hemp industry’s national advocacy organization, welcomes them—but asks them to join us in a framework that rejects prohibition, embraces regulation, prevents access by minors and protects retail and e-commerce for all elements of the diverse hemp industry.

Since the 2018 Farm Bill federally legalized hemp, it’s been a rollercoaster ride. After a brief gold rush, the Food and Drug Administration’s (FDA) refusal to regulate CBD led to a crash in prices and widespread disruption. But with a hemp industry as resilient as its stalk, innovators pioneered direct-to-consumer (DTC) sales and developed a new market for adult health and wellness products–including a hemp beverage boom which now meets growing demand for non-alcoholic options.

Today, the hemp extract market has surged to $28.4 billion, creating 328,000 agriculture and retail jobs, with a $13.2 billion employment impact and $1.5 billion generated in state tax revenues. Its popularity is not surprising—hemp products are made in the USA, harvested from crops grown by American farmers, manufactured by innovative U.S. entrepreneurs and sold by small businesses dotting the nation.

Competing interests have taken note of hemp’s success. A few marijuana multi-state operators (MSOs) have led efforts at the state and federal level to ban hemp products, and/or seek monopoly control over distribution. But the majority of marijuana advocates support regulation, not prohibition. In fact, many cannabis companies have found new life via hemp. We’re excited to join an emerging new effort to bring the entire cannabis family together in a united policy-making venture.

More recently, the alcohol industry is weighing in as hemp beverages have gained space on shelves previously reserved for liquor. Leading organizations such as the Wine & Spirits Wholesalers of America and the American Beverage Licensees have called for Congress and state legislators to explicitly legalize and regulate hemp beverages, which in 2024 boasted $380 million in revenues.

But warning clouds loom. In some states, efforts to regulate beverages include bans on other types of hemp products, such as edibles or CBD tinctures fully 85 percent of the hemp product marketplace). In others, there is a rush to ban DTC sales—a lifeline to hundreds of thousands of adult consumers.

Texas has emerged as a key battleground. In response to Lt. Gov. Dan Patrick’s (R) crusade to criminalize all hemp products, HB 28 was introduced as a hemp beverage carveout. Unfortunately, that bill would ban nearly all non-beverage hemp products, criminalize DTC and dramatically reduce the number of retailers who can sell these products.

Keep reading

Trump’s DEA Pick Refuses To Detail Marijuana Rescheduling Stance In Response To Senator’s Questions

In written responses to questions from two Democratic senators as part of his confirmation, the nominee for DEA administrator, Terrance Cole, largely demurred on multiple questions around marijuana policy issues, including a pending proposal to move cannabis from Schedule I to Schedule III that was initiated under the Biden administration.

Asked by Sens. Cory Booker (D-NJ) and Alex Padilla (D-CA) about his position on that proposal, Cole—who has previously voiced concerns about the dangers of marijuana and linked its use to higher suicide risk among youth—simply said that, if confirmed, he will “give the matter careful consideration after consulting with appropriate personnel within the Drug Enforcement Administration, familiarizing myself with the current status of the regulatory process, and reviewing all relevant information.”

While he gave noncommittal answers when asked about rescheduling in the written questions, Cole said during an in-person hearing before the Senate Judiciary Committee last month that examining the rescheduling proposal will be “one of my first priorities” if he’s confirmed for the role, saying it’s “time to move forward” on the stalled process—but again without clarifying what end result he would like to see.

“I’m not familiar exactly where we are, but I know the process has been delayed numerous times—and it’s time to move forward,” he told Padilla at the time. “I need to understand more where [agencies] are and look at the science behind it and listen to the experts and really understand where they are in the process.”

In the newly released written questions, Booker further asked the nominee whether he felt DEA is “bound” by the scheduling process as articulated under the Controlled Substances Act (CSA).

“As in all matters, if confirmed, I would look at the individualized facts and circumstances and follow the law and any policies of the Department,” Cole said.

Keep reading

New York Governor Signs Budget After Lawmakers Remove Her Plan To Let Police Use Marijuana Odor Against Drivers

The state budget bill signed into law by New York Gov. Kathy Hochul (D) on Friday notably does not include a controversial marijuana provision the governor proposed earlier this year that would have allowed police to use the smell of marijuana as probable cause that a driver is impaired and then force them to take a drug test.

Amendments made in the legislature this week removed the provision, which a coalition of 60 reform groups had argued in a letter to Hochul and top lawmakers would “repeat some of the worst harms of the War on Drugs” and allow law enforcement to “restart unconstitutional racial profiling of drivers.”

The governor’s plan drew criticism from not just reform advocates but also the state’s Assembly majority leader and the governor-appointed head of the Office of Cannabis Management (OCM), who’d previously said the plan would undermine the goals of legalization and was “not going to work for New York.”

Historically, New York has been home to some of the country’s starkest racial disparities when it comes to enforcement of laws against marijuana. For example, Black people in New York City in the 2010s were more than nine times more likely to be arrested for marijuana possession than white people.

In Hochul’s original budget bill, a line would have added “the odor of cannabis, burnt cannabis or other drug” as a “reasonable cause” for law enforcement to stop and search a vehicle. An amended bill approved by lawmakers this week, however, removed that provision.

After both chambers approved the changes, the legislation went to the governor on Thursday and was signed into law the next day.

As for other cannabis-related provisions in the new state budget, one change eliminates the $229,000 annual salary for the chair of the state’s Cannabis Control Board (CCB).

That official, Tremaine Wright, said this week that she will not leave her post.

Keep reading

Using Marijuana Reduces Alcohol Cravings In People Who Drink A Lot, Federally Funded Study Shows

New federally funded research into the effects of cannabis on alcohol use finds that people who used marijuana immediately before drinking subsequently consumed fewer alcoholic beverages and reported lower cravings for alcohol.

“We found that across the entire sample, self-administering cannabis before alcohol significantly reduced alcohol consumption compared to when alcohol was offered without cannabis,” authors wrote in a study preprint published late last month on the open-access website PsyArXiv.

“Furthermore,” they continued, “we found that cannabis and alcohol co-administration was associated with significant acute reduction in alcohol craving compared to alcohol administration alone.”

The study, funded by the National Institutes of Health’s National Institute of Alcohol Abuse and Alcoholism, provides further evidence of a substitution effect, in which users report replacing some or all of their alcohol use with cannabis.

An eight-person research team from Colorado State University and the University of Colorado looked at the behavior of 62 adults who used both marijuana and alcohol and who engaged in heavy drinking for at least three months.

Each person participated in two separate sessions in which they could drink up to five alcoholic beverages—an initial priming drink, followed by up to four more optional drinks offered at 15-minute intervals.

In one of the two sessions, participants were first directed to consume marijuana in a manner of their choosing and at their typical dose, which was weighed and recorded.

When subjects used alcohol alone, they drank on average two self-administered beverages. With cannabis added to the mix, the average number of self-administered drinks was 1.5—roughly 25 percent lower.

And while not every participant drank less after using marijuana, those who did “reported reductions in alcohol craving at several timepoints after consuming cannabis and alcohol compared to alcohol alone,” the report says.

Alcohol cravings among those who drank more or the same after consuming cannabis either stayed level or increased, it notes.

The study concludes that “for some individuals who drink heavily, cannabis may serve as a substitute for alcohol, and craving reduction may be the mechanism through which this occurs.”

Keep reading

Trump Administration’s DOGE Cancels University’s Contract To Monitor Marijuana Potency

The Trump administration’s Department of Government Efficiency (DOGE) is touting the cancellation of another marijuana-related federal grant—this time targeting a program that’s long tracked cannabis potency levels in seized illicit products.

The contract has historically been awarded to the University of Mississippi, which for decades was the sole federally authorized cultivator of marijuana for research purposes. But it’s also received funding through the National Institute on Drug Abuse (NIDA) to monitor cannabinoid content such as THC and CBD in confiscated cannabis.

That contract has now been ended as part of DOGE’s mission to make significant government spending cuts.

“In the last two days, agencies terminated 148 wasteful contracts with a ceiling value of $420M and savings of $198M, including a $143K HHS contract for the ‘potency monitoring of confiscated marijuana samples,’” DOGE said in an X post on Monday.

Keep reading

Researchers Announce They’ve Discovered A New Cannabinoid In Marijuana

Researchers have announced that they’ve successfully identified a new cannabinoid—cannabielsoxa—produced by the marijuana plant as well as a number of other compounds “reported for the first time from the flowers of C. sativa.”

The team of government and university researchers out of South Korea also evaluated 11 compounds in cannabis for antitumor effects in neuroblastoma cells, finding that seven “revealed strong inhibitory activity.”

Authors said the findings represent “an initial step toward developing a product for the treatment of neuroblastoma,” a cancer they note “is the most common solid tumor in children and the most frequent malignancy in the first year of life.”

Published this month in the journal Pharmaceuticals, the paper says researchers used chromatographic techniques to isolate the compounds. They then examined their molecular structures and used a metabolic testing method to assess their toxicity to neuroblastoma cells.

“This study successfully isolated a new cannabinoid and six known cannabinoid compounds, along with a new chlorin-type compound and three additional chlorine-type compounds,” the study says, “which were reported for the first time from the flowers of C. sativa.”

Two of the compounds identified for the first time in cannabis—132-hydroxypheophorbide b ethyl ester and ligulariaphytin A—are described as “chlorin-type compounds.”

They, along with five other known cannabinoids—cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidiolic acid methyl ester (CBDA-ME), delta-8 THC and cannabichromene (CBG)—”could be considered as the potential compounds for antitumor effects against neuroblastomas,” researchers found.

Results of the antitumor analyses “demonstrated that cannabinoid compounds had stronger inhibitory effects on neuroblastoma cells than chlorin-type compounds,” the paper notes.

The new cannbinoid, cannabielsoxa, was not among the compounds that researchers identified as potentially toxic to neuroblastoma cells, however.

Keep reading